Why on earth would this child need the MMR, having already had the measles? Who, other than the vaccine manufacturers, could possibly benefit from such a recommendation? - SM
http://www.thetimes.co.uk/article/0,,72-2002034705,00.html
|
TUESDAY JANUARY 22 2002 |
|
|
|
|
|
|
|
BY DR JANE
COLLINS |
|
|
|
The Times children's doctor answers readers' questions |
|
|
|
Q: Do post-measles babies still need the
MMR jab? My two elder sons both had the MMR
vaccination because I was prepared to accept that risks from the vaccination
were lower than the risks from the diseases themselves. My youngest son is
now due for his MMR but contracted measles at the age of nine months. My
health visitor says that he should still have the triple vaccine, but I feel
I am being fed the party line because I know that my surgery does not give
single doses. What is your advice? A: Your health visitor has given you good advice. Even
though your son was diagnosed with measles, it is possible that he could have
had something else. A previous clinical diagnosis of any of the three
diseases — measles, mumps or rubella — is not a reliable indicator of whether
or not a child had the disease. Tests carried out two years ago to confirm
measles found that only 75 of 1,750 reported cases were truly measles. The
rest were other illnesses. But as uptake of the MMR vaccine has fallen,
especially in London, we are increasingly at risk of seeing these three
diseases again. You might think that a blood test would reveal
whether your son is immune to measles. In fact blood tests available to check
for immunity are designed to confirm an acute measles infection and have not
been validated as a means to detecting reliably for immunity. Even if your son is immune, there is no problem
with him receiving the MMR vaccine. MMR contains three live but weakened
viruses. Each vaccine virus will not build up to a significant level in
someone who already has immunity to that infection. The vaccine has a good safety profile, having
been given to children under the age of two in the United States for almost
30 years. It is used in more than 90 countries and is highly effective. Its
use in the UK has resulted in a dramatic decline in measles, mumps and rubella,
but a high vaccine uptake is essential to continue to protect children
against these three potentially serious infections. |